// App-Quantinova.ai

2548 : Association of hypertension and proteinuria with overall survival in solid-tumor patients treated with anti-VEGF drugs in the MARS study.

Researchers

Presenter

  • Vincent Launay-Vacher

Principal Investigators

  • Isabelle Laure Ray-Coquard

  • Jean-Baptiste Rey

  • Christelle Jouannaud

  • Jean F. Morere

  • Stephane Oudard

  • Florian Scotte

  • Michel Azizi

  • Richard Dorent

  • Joseph Gligorov

  • Frederic Selle

  • Francois Goldwasser

  • Olivier Mir

  • Jean-Philippe Spano

  • Jean Christophe Thery

  • Gilbert Deray

  • Philippe Beuzeboc

  • Catherine Daniel

Medical Centers

  • Service ICAR - Pitie-Salpetriere Hospital, Paris, France

  • Universite Pierre et Marie Curie, Oncology, GHU-Est Tenon, Paris, France

  • Assistance Publique-Hopitaux de Paris, Tenon APREC, CancerEst, University Paris VI, Paris, France

  • Cochin Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cite, Paris, France

  • Hopital Cochin, Paris, France

  • Department of Pathology, Hopital Europeen Georges Pompidou, APHP - Paris Descartes University, Paris, France

  • Oncology Department, Institut Curie, Paris, France

  • Cardiology Department, Hopital Tenon, Paris, France

  • Medical Oncology Department, AP-HP, Salpetriere Hospital, University Paris VI, Paris, FranceMedical Oncology, Institut Jean Godinot, Clermont-Ferrand, FranceDepartment of Medical Oncology, Pitie-Salpetriere University Hospital, Paris, France

  • Centre Leon Berard, Lyon, France

  • Nephrology, Pitie-Salpetriere Hospital, Paris, France

  • Oncology Department, Bobigny, France

  • Pharmacy Department, Institut Jean Godinot, Reims, France

  • Supportive Care Unit, Medical Oncology Department, Georges Pompidou European Hospital, Paris, France

  • Arterial Hypertensive Department, Hopital en Georges Pompidou, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hypertension

  • Albuminuria

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved